← Back to Search

Corticosteroid

Betamethasone for Trigger Finger

Phase 4

Waitlist Available

Led By Shatic Sraj, MD

Research Sponsored by West Virginia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 7 days

Awards & highlights

Study Summary

This trial is testing whether one of two common corticosteroids is better at treating trigger finger, with the goal of reducing pain.

Eligible Conditions

Trigger Finger

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Incidence of Flare Reaction

Incidence of Pain

Intensity of Pain

Trial Design

2Treatment groups

Active Control

Group I: BetamethasoneActive Control1 Intervention

betamethasone

Group II: MethylprednisoloneActive Control1 Intervention

methylprednisolone

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor

175 Previous Clinical Trials

56,240 Total Patients Enrolled

Shatic Sraj, MDPrincipal InvestigatorWest Virginia University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has Methylprednisolone passed regulatory muster for commercial use?

"Methylprednisolone is a Phase 4 treatment, which has been approved for use, thus it obtained the highest safety rating of 3."

Answered by AI

Does this trial currently have availability for participants?

"According to current information hosted on the clinicaltrials.gov website, this trial is actively seeking participants. This research project was initially published on September 15th 2021 and has been recently updated as of April 26th 2022."

Answered by AI

What conditions is Methylprednisolone typically employed to manage?

"Methylprednisolone is primarily used to treat scalp structure, but it has been known to alleviate dermatitis and atopic issues as well as multiple sclerosis and ulcerative colitis."

Answered by AI

Are there any antecedent studies involving Methylprednisolone?

"Currently, 163 clinical trials involving Methylprednisolone are in progress; 43 of which have entered Phase 3. Houston, Texas is the epicentre for these studies, but they span 6962 different sites across the world."

Answered by AI

What is the intake capacity of this experiment?

"Affirmative. According to the clinicaltrials.gov listing, this trial was initially posted on September 15th 2021 and is actively seeking volunteers with its last update occurring on April 26th 2022. 100 participants are needed from 2 different medical hubs."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections

Shafic Sraj, MD 2021. "Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04900220.